Analyst Ratings for Evoke Pharma (EVOK)
Avg. $ Target:
N/A
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/6/2025 | Laidlaw | Yale Jen | Downgrade | Hold (Buy) |
N/A (N/A) |
10.69 (11.00) |
2.9% | Details |
| 6/22/2020 | H.C. Wainwright | Raghuram Selvaraju | Upgrade | Buy (Neutral) |
10.00 (N/A) |
2.35 (11.00) |
368.09% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
